Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset

The Company Reported 73% Clinical Clearance in the 200-µg cohort at Day 57PHILADELPHIA, March 09, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a ...
MobileSyrup

iPad Air M4 Review: A mother and son’s perspectives

I’m certainly more than familiar with the ecosystem, both because I bought my mother and grandparents iPads and I have an ...